MedPath

Testing the efficacy of remineralising toothpaste containing calcium sucrose phospate, casein phospopeptide amorphous calcium phosphate fluoride and nanohydroxyapatite in the prevention of white spot lesions in people with metal braces

Phase 4
Conditions
Health Condition 1: K038- Other specified diseases of hard tissues of teeth
Registration Number
CTRI/2024/02/062619
Lead Sponsor
MIDSR Dental College Latur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patient with age between 15-25 years undergoing fixed orthodontic treatment with metal brackets.

2. Patients with satisfactory general health.

3. Patients with good and fair oral hygiene

4. Patients with mild dental crowding

5. Patients participating in the study voluntarily

Exclusion Criteria

1) Enamel hypoplasia

2) Amelogenesis imperfecta

3) Fluorosis

4) Active periodontal disease

5) Active dental caries

6) Patients having frontal fillings, veneers, or other reconstructions

7) Patients having other structural defects of enamel.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the effectiveness of three remineralizing agents; calcium sucrose phosphate, casein phosphopeptide-amorphous calcium phosphate fluoride (CPP-ACP) and nanohydroxyapatite in prevention of white spot lesions in patients undergoing fixed orthodontic treatment.Timepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
To evaluate the first appearance of white spot lesions with the use of calcium sucrose phosphate, casein phosphopeptide-amorphous calcium phosphate fluoride and nanohydroxyapatite.Timepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath